
Ketone Esters
Ketone ester drinks reliably raise blood ketones for a few hours. A meta-analysis of 43 trials found that exogenous ketones lower blood sugar for a few hours after a dose, more with esters than with salts, and trials in type 2 diabetes found lower blood sugar after a meal; but 14 days of use did not improve blood sugar control in a controlled trial. Two meta-analyses found no benefit for exercise performance, and one trial found lower cycling power. Small trials in heart failure showed better heart pumping measures over 2 weeks, but no better exercise capacity. A 2026 meta-analysis found a small cognitive benefit from exogenous ketones in general. Most studies were short and small.
Quick decision guide
May help most
Adults curious about short-term effects who accept that the evidence is mostly from small, short laboratory studies; people with heart failure or diabetes only inside a trial or with their doctor
Common dosing range
Studied amounts, not recommendations: single doses of 0.3 to 0.5 g per kg of body weight (about 20 to 35 g for a 70 kg adult), 10 to 40 g before a meal, and 25 ml (26.8 g) three times a day for 28 days in healthy adults
When to expect effects
Blood ketones rise within minutes, peak within about 1 to 2 hours of a dose and fall over a few hours; trial effects were measured within hours or after 2 weeks
Watch out for
Stomach upset (nausea, diarrhea) is the most common side effect, more likely with large doses. It lowers blood sugar for a few hours, so people taking diabetes medicines should talk to their doctor first. Long-term safety beyond 28 days in healthy adults has not been studied. It is not proven to improve sports performance
What is it
Ketone esters are drinks and gels that raise the level of ketones in the blood without fasting or a ketogenic diet. The one used in most human studies is a ketone monoester, (R)-3-hydroxybutyl (R)-3-hydroxybutyrate, also labeled D-beta-hydroxybutyrate ester. In the US it is used as a food ingredient: FDA closed a GRAS (generally recognized as safe) notice for a D-beta-hydroxybutyrate ester for use in bars, gels and beverages in 2015 with a "no questions" letter. Ketone esters are not the same as ketone salts (BHB bound to sodium, potassium, calcium or magnesium): in a direct comparison the ester raised blood ketones almost three times as high, and the salts contained half of a form (L-BHB) the ester does not. Most trials are short, small and done in laboratories, so the long-term effects are not known.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
short-term blood sugar after a dose Good Evidence | Blood glucose about 0.47 mmol/L lower than placebo after a dose; 18 to 36% smaller rise after a meal in type 2 diabetes | Adults in short laboratory studies, including people with type 2 diabetes treated with diet or metformin | Within 30 minutes to 4 hours of a dose |
exercise performance and recovery Good Evidence | No difference from placebo in pooled analyses; 2.4% lower power in one trial | Trained, mostly male athletes, as studied | Tested 30 to 60 minutes after a dose |
blood sugar control over 2 weeks in type 2 diabetes Limited Evidence | No difference from placebo in fructosamine after 14 days | Adults with type 2 diabetes, as studied | 14 days studied |
thinking and attention Limited Evidence | Small: standardized mean difference 0.29 across exogenous ketones | Healthy adults and people with Alzheimer's disease in short trials | Measured within hours of a dose in most trials |
heart pumping measures in heart failure Limited Evidence | Cardiac output 0.2 to 0.6 L/min higher at rest; no gain in exercise capacity where it was measured | People with heart failure taking part in trials, on top of standard treatment | Hours to 14 days |
ALS (amyotrophic lateral sclerosis) Limited Evidence | No significant difference in the primary outcome; no benefit on function | People with ALS, as studied | 6 months studied |
short-term blood sugar after a dose
- Effect
- Blood glucose about 0.47 mmol/L lower than placebo after a dose; 18 to 36% smaller rise after a meal in type 2 diabetes
- Best fit
- Adults in short laboratory studies, including people with type 2 diabetes treated with diet or metformin
- Time
- Within 30 minutes to 4 hours of a dose
exercise performance and recovery
- Effect
- No difference from placebo in pooled analyses; 2.4% lower power in one trial
- Best fit
- Trained, mostly male athletes, as studied
- Time
- Tested 30 to 60 minutes after a dose
blood sugar control over 2 weeks in type 2 diabetes
- Effect
- No difference from placebo in fructosamine after 14 days
- Best fit
- Adults with type 2 diabetes, as studied
- Time
- 14 days studied
thinking and attention
- Effect
- Small: standardized mean difference 0.29 across exogenous ketones
- Best fit
- Healthy adults and people with Alzheimer's disease in short trials
- Time
- Measured within hours of a dose in most trials
heart pumping measures in heart failure
- Effect
- Cardiac output 0.2 to 0.6 L/min higher at rest; no gain in exercise capacity where it was measured
- Best fit
- People with heart failure taking part in trials, on top of standard treatment
- Time
- Hours to 14 days
ALS (amyotrophic lateral sclerosis)
- Effect
- No significant difference in the primary outcome; no benefit on function
- Best fit
- People with ALS, as studied
- Time
- 6 months studied
Evidence for 6 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
short-term blood sugar after a dose
Biomarker supportA 2022 systematic review and meta-analysis of 43 trials (586 participants) found that exogenous ketones raised blood BHB by 1.98 mmol per liter and lowered blood glucose by 0.47 mmol per liter (about 8 mg/dL) compared with placebo, with larger effects for ketone monoesters than for ketone salts. Most studies tested a single dose, and the review found limited evidence on longer use. In adults with type 2 diabetes, a crossover trial in 10 people found that 0.5 g per kg of a ketone monoester before a meal lowered blood glucose by about 18% over 2 hours and 12% over 4 hours, mainly by slowing the entry of meal glucose into the blood, with no adverse effects observed. A 2026 trial in 14 people with type 2 diabetes found that 30 g of a ketone monoester 30 minutes before a meal lowered the rise in blood sugar by 36% (95% CI 14 to 57) compared with placebo, and ketone salts by 22% (95% CI 1 to 44); mild, short-lived nausea and diarrhea were reported. That trial was funded by the Novo Nordisk Foundation and other foundations, and one author co-founded a company developing a different ketone ester.
Bottom line: A dose lowers blood sugar for a few hours, more with esters than with salts; this is a short-term blood marker effect.
exercise performance and recovery
No benefit foundA 2020 meta-analysis of 13 randomized controlled trials found no effect of a single dose of ketone supplements on exercise performance (Hedges g -0.05, 95% CI -0.30 to 0.20), including for ketone esters alone (g -0.07), in efforts from sprints to about 50 minutes. A 2022 meta-analysis of 8 trials (80 participants, 77 of them men) also found no effect on endurance performance (g 0.14, 95% CI -0.20 to 0.47). In a later trial, 23 trained cyclists produced 2.4% less power in a 20-minute time trial after 0.35 g per kg of the ketone monoester than after placebo (255 versus 261 watts). An early 2016 report of five studies in 39 high-performance athletes described better endurance with a ketone ester drink, but later trials did not confirm a consistent benefit. A 2026 meta-analysis of recovery after exercise found no effect on muscle soreness or glycogen refilling.
Bottom line: Ketone esters do not improve exercise performance or recovery on current evidence, and one trial found them worse than placebo.
blood sugar control over 2 weeks in type 2 diabetes
No benefit foundTwo placebo-controlled crossover trials in adults with type 2 diabetes tested whether a ketone monoester improves blood sugar control. A single dose of 0.3 g per kg taken fasting (18 people) did not lower plasma glucose, and 15 g three times a day before meals for 14 days (15 people) did not change fructosamine, a marker of average blood sugar over 2 to 3 weeks, or fasting measures. The trials were funded by the Canadian Institutes of Health Research. An earlier study without a control group, in 21 people with type 2 diabetes who drank 25 ml three times a day for 4 weeks, reported HbA1c falling from 7.7% to 7.2%; without a placebo group that result cannot be attributed to the drink, and one author declared a share of royalties on ketone ester intellectual property and is a director of TdeltaS, a company developing ketone products.
Bottom line: In the only controlled trial of repeated use, 2 weeks of ketone ester did not improve blood sugar control in type 2 diabetes.
Evidence is mixed
An uncontrolled 4-week study reported lower HbA1c, but the placebo-controlled 14-day trial found no change in fructosamine.
thinking and attention
Supplement benefitA 2026 systematic review and meta-analysis of randomized trials of exogenous ketones (esters, salts and other forms together) pooled 29 study protocols with 1,117 participants and found a small improvement in cognitive test performance compared with placebo (standardized mean difference 0.29, 95% CI 0.16 to 0.41), with larger effects at higher daily doses. The review did not find a significant difference between ketone types, and several authors declared financial ties to companies that sell ketone products. In a 2026 crossover trial in 18 older men with overweight, one dose of the ketone monoester (395 mg per kg) modestly improved attention and psychomotor speed (reaction time 9 milliseconds shorter, 95% CI 1 to 18 milliseconds shorter) but did not change memory or executive function. These are mostly single-dose tests; no trial showed prevention of cognitive decline.
Bottom line: Exogenous ketones may slightly improve test scores for a few hours; long-term brain effects are unknown.
heart pumping measures in heart failure
Biomarker supportIn a double-blind crossover trial, 24 people with heart failure with reduced ejection fraction (65 years on average, without diabetes) took a ketone ester four times a day for 14 days or a comparator with the same calories. Resting cardiac output was higher with the ester (5.2 versus 5.0 liters per minute) and the pressure in the heart's filling chambers was lower (8 versus 11 mm Hg); exercise capacity did not differ. In a similar 2-week crossover trial in 24 people with type 2 diabetes and heart failure with preserved ejection fraction, 25 g four times a day raised cardiac output by 0.2 liters per minute and lowered filling pressure at peak exercise by 5 mm Hg. A third trial, in 20 people with heart failure with preserved ejection fraction, found that one dose raised resting cardiac output but did not improve peak oxygen uptake (10.4 versus 10.5 mL/kg/min) or endurance time. None of these trials measured hospital admissions, symptoms over time or survival.
Bottom line: Two-week trials show better heart pressure and output measures in heart failure, but no better exercise capacity and no outcome data.
Evidence is mixed
Hemodynamic measures improved in two 2-week trials, but exercise capacity did not improve in the two trials that reported it.
ALS (amyotrophic lateral sclerosis)
No benefit foundIn a 6-month randomized, placebo-controlled phase 2 trial, 81 people with ALS took 30 g a day of a D-beta-hydroxybutyrate ester or placebo. The main outcome, the change in a blood marker of nerve damage (neurofilament light chain), did not differ significantly in the unadjusted analysis (p = 0.094); an adjusted analysis favored the ester, but a mixed-effects model did not. On the ALS functional rating scale, the unadjusted decline was faster in the ester group (1.4 versus 0.8 points a month), with no difference after adjustment. The ester was tolerated as well as placebo. The trial was funded by a private donation, and the authors call for a larger trial.
Bottom line: In the one placebo-controlled trial in ALS, a ketone ester did not clearly slow the disease.
How it works
How to take it
What to track
Bottom line: It raises blood ketones and lowers blood sugar for a few hours; lasting health benefits have not been shown.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Long-term safety is unknown. The longest safety study in healthy adults lasted 28 days: 24 people aged 18 to 70 drank 26.8 g three times a day and had no changes in body weight, fasting blood sugar, cholesterol, triglycerides, electrolytes, blood gases or kidney function. An earlier 5-day study at up to 2.14 g per kg a day found it generally well tolerated, with some stomach effects at the highest dose. A 6-month trial in 81 people with ALS found similar rates of adverse events with the ester and placebo. Rare or long-term effects would not have been detected in these studies.
Lower blood sugar for a few hours after a dose, larger with esters than with salts. In the trials this was the effect being studied, and none reported serious adverse events; one trial included only people treated with metformin or lifestyle changes, and the blood sugar trials we read did not report results for people using insulin or sulfonylureas.
A small, short-term change in blood acidity. In a metabolic study, a ketone ester drink lowered blood pH by 0.10, while ketone salts made the urine more alkaline (pH 5.7 to 8.5); blood electrolytes stayed normal with both.
Who should avoid it
- People taking insulin or other medicines that lower blood sugar, unless their doctor agrees, because a dose lowers blood sugar for a few hours
- Athletes before competition who expect a performance boost: one trial found lower power output after a dose
Pregnancy & breastfeeding
Pregnancy and breastfeeding: we found no studies of ketone esters in pregnant or breastfeeding women, and the trials we read enrolled adults outside pregnancy. Safety is unknown. Ask your obstetric clinician or pharmacist before using them while pregnant, trying to conceive or breastfeeding.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
What is the difference between ketone esters and ketone salts?⌄
Ketone salts are BHB bound to minerals such as sodium and potassium; ketone esters bind BHB to another molecule without minerals. In a study that compared them, the ester raised blood D-BHB to 2.8 mmol per liter and the salts to 1.0 mmol per liter, and half of the BHB in the salts was L-BHB, a form that stayed in the blood for more than 8 hours. A meta-analysis found larger blood sugar drops with monoesters than with salts. Salts also deliver a load of the minerals they are bound to.
Do ketone esters improve athletic performance?⌄
Not on current evidence. Two meta-analyses of randomized trials found no effect on exercise performance, and a 2023 trial in 23 trained cyclists found 2.4% lower power in a 20-minute time trial after a dose. A 2026 meta-analysis found no benefit for recovery after exercise.
Are ketone esters legal and regulated in the US?⌄
As a food ingredient, for set uses. FDA's GRAS notice inventory lists GRN 515, a D-beta-hydroxybutyrate ester notified by TdeltaS Limited for use in bars, gels and beverages at a level intended to provide 0.36 g per kg of body weight per serving; FDA closed the notice on March 5, 2015 with a letter saying it had no questions. That concerns this ester's use in food at that level, not other ketone products and not any health claim.
Will ketone esters help me lose weight?⌄
There is no evidence that they do. In a 28-day study, healthy adults who drank a ketone monoester three times a day had no change in body weight or body composition. Each drink also contains calories.
Can I take ketone esters with my medicines or supplements?⌄
No interaction studies exist, and our database lists no interactions for ketone esters. Because a dose lowers blood sugar for a few hours, people taking diabetes medicines should ask their doctor first. Ask your doctor or pharmacist to check your full list.
Do ketone esters help people with heart failure or diabetes?⌄
Small trials show short-term changes: better heart pressure and output measures after 2 weeks in heart failure, and lower blood sugar after a meal in type 2 diabetes. But exercise capacity in heart failure did not improve, 14 days of use did not improve blood sugar control in diabetes, and no trial has measured hospital admissions or survival. These are research findings, not a treatment; talk to your doctor.
References by claim
short-term blood sugar after a dose
blood sugar control over 2 weeks in type 2 diabetes
exercise performance and recovery
thinking and attention
heart pumping measures in heart failure
ALS (amyotrophic lateral sclerosis)
Herrmann et al., 2026 · PMC (2026) link
Track Ketone Esters with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments. Talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.
